A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections -- including SARS-CoV-2

When it comes to COVID-19, women seem to be the stronger sex, suffering severe disease at about half the rate as men, but the reason for this has been elusive.

Twin 9-year-old girls at Duke Health became the first in the United States to participate in Pfizer and BioNTech Phase 1 study to evaluate safety, tolerability and immunogenicity of the Pfizer-BioN

Dean Klotman narrates a video of highlights from the past year and offers her thanks for the commitment of faculty, staff and students to fulfilling the missions of excellence in patient care, research and discovery, education and community service.

As a next step in Duke University’s exhaustive, campus-wide testing program during the Covid pandemic, the university is employing a genome sequencing core facility in downtown Durham to identify t

The mental health challenges associated with the COVID-19 pandemic have overwhelmed many Americans.

The African American COVID Taskforce Plus (AACT+) includes members from more than 20 organizations

A Duke COVID-19 study tracking the pandemic in Cabarrus County is contributing data to a statewide research network monitoring the coronavirus in sewer systems to help inform the public health resp

State leaders and education officials weighing whether to re-open schools are considering myriad factors, from infection rates to vaccine rollout to a reluctance on the part of both teachers and fa

As communities grappled with how to get children and teenagers back to school safely during the COVID-19 pandemic, Zimmerman, MD, MPHS, was confident that she and her colleagues at Duke could help. She saw questions that needed to be answered, and she went to work.